Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study
Baseline urinary symptoms are associated with late urinary toxicity; patients with worse symptoms should be counselled on their elevated risk and consider moderate hypofractionation. The observed association between treatment technique and toxicity may reflect variations in urinary medication prescribing practices and warrants further validation.
Authors
- Ragu Ratnakumaran
- Nicholas van As (ORCID: https://orcid.org/0000-0001-6829-8788)
- Jonathan Mohajer (ORCID: https://orcid.org/0000-0002-7097-3225)
- Alison Tree (ORCID: https://orcid.org/0000-0002-5033-424X)
- Andrew Loblaw (ORCID: https://orcid.org/0000-0002-4883-1781)
- Douglas Brand (ORCID: https://orcid.org/0000-0003-1130-4520)
- Emma Hall (ORCID: https://orcid.org/0000-0001-5999-5020)
- Asadullah Khan (ORCID: https://orcid.org/0000-0001-8067-0124)
- Victoria Hinder
- Archana Sasitharan
- Hira Mayet
Institutions
- Sunnybrook Health Science Centre (CA)
- Royal Marsden NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
- Health Sciences Centre (CA)
- University College London (GB)
Publication Details
- Journal
- European Urology
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1016/j.eururo.2025.07.007
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52